For 133 (32.6%) patients, microsatellite instability (MSI) status was available; including 29 of the 30 patients with tumor tissue BRAF mutation and 26 of the 27 patients with BRAF plasma mutation. The gene discussed is BRAF; the disease is neoplasm.